• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

草酸钙大分子沉淀抑制剂的研究

Investigations on macromolecular precipitation inhibitors of calcium oxalate.

作者信息

Schnierle P, Sialm F, Seiler H G, Hering F, Rutishauser G

机构信息

Institute for Inorganic Chemistry, University of Basle, Switzerland.

出版信息

Urol Res. 1992;20(1):7-11. doi: 10.1007/BF00294327.

DOI:10.1007/BF00294327
PMID:1736490
Abstract

Certain important aspects of the urine oxalate tolerance test (OTT) have been revised. The stirring system has been changed and the test has been adapted to the kinetics of calcium oxalate precipitation. True equilibrium conditions are now ensured during the measurements. Furthermore, the endogenous oxalate concentration is determined and taken into consideration. As a result of these changes, the significance of the test results has greatly improved. The effects of the addition of small amounts of zinc on the precipitation of calcium oxalate have been used in a new variation of the OTT. This new test makes it possible to discriminate much faster and more simply between recurrent stone-formers and other subjects. Tamm-Horsfall protein (THP) has been tested for its effect on the precipitation of calcium oxalate by means of OTT. THP inhibits the precipitation of calcium oxalate, but THP of stone-formers has a diminished inhibitory activity. The inhibitory activity of this protein strongly depends on the method by which it is isolated.

摘要

尿草酸耐受性试验(OTT)的某些重要方面已得到修订。搅拌系统已更改,并且该试验已适应草酸钙沉淀的动力学。现在在测量过程中确保了真正的平衡条件。此外,内源性草酸盐浓度被测定并予以考虑。由于这些变化,试验结果的意义有了很大提高。在OTT的新变体中利用了添加少量锌对草酸钙沉淀的影响。这种新试验能够更快、更简单地区分复发性结石形成者和其他受试者。已通过OTT测试了Tamm-Horsfall蛋白(THP)对草酸钙沉淀的影响。THP抑制草酸钙沉淀,但结石形成者的THP抑制活性降低。这种蛋白质的抑制活性很大程度上取决于其分离方法。

相似文献

1
Investigations on macromolecular precipitation inhibitors of calcium oxalate.草酸钙大分子沉淀抑制剂的研究
Urol Res. 1992;20(1):7-11. doi: 10.1007/BF00294327.
2
Effect of Tamm-Horsfall protein on calcium oxalate precipitation.Tamm-Horsfall蛋白对草酸钙沉淀的影响。
Eur J Clin Chem Clin Biochem. 1995 Oct;33(10):705-10. doi: 10.1515/cclm.1995.33.10.705.
3
Role of Tamm-Horsfall protein and uromodulin in calcium oxalate crystallization.Tamm-Horsfall蛋白和尿调节蛋白在草酸钙结晶中的作用。
Braz J Med Biol Res. 2002 Oct;35(10):1165-72. doi: 10.1590/s0100-879x2002001000009. Epub 2002 Oct 13.
4
Effects of urinary macromolecules on the nucleation of calcium oxalate in idiopathic stone formers and healthy controls.尿大分子对特发性结石形成者和健康对照者草酸钙成核的影响。
Clin Chim Acta. 1995 Jul 31;239(1):1-11. doi: 10.1016/0009-8981(95)06092-r.
5
Calcium oxalate stone agglomeration reflects stone-forming activity: citrate inhibition depends on macromolecules larger than 30 kilodalton.草酸钙结石聚集反映结石形成活性:柠檬酸盐抑制作用取决于分子量大于30千道尔顿的大分子。
Am J Kidney Dis. 1994 Dec;24(6):893-900. doi: 10.1016/s0272-6386(12)81057-2.
6
Relationship between supersaturation and calcium oxalate crystallization in normals and idiopathic calcium oxalate stone formers.正常人及特发性草酸钙结石患者中过饱和度与草酸钙结晶的关系。
Kidney Int. 1999 Mar;55(3):1041-50. doi: 10.1046/j.1523-1755.1999.0550031041.x.
7
The dual effect of urinary macromolecules on the crystallization of calcium oxalate endogenous in urine.尿液中大分子物质对尿液内源性草酸钙结晶的双重作用。
Urol Res. 1992;20(1):13-7. doi: 10.1007/BF00294328.
8
Tamm-Horsfall protein in recurrent calcium kidney stone formers with positive family history: abnormalities in urinary excretion, molecular structure and function.有阳性家族史的复发性钙肾结石患者的Tamm-Horsfall蛋白:尿排泄、分子结构及功能异常
Urol Res. 2007 Apr;35(2):55-62. doi: 10.1007/s00240-007-0083-7. Epub 2007 Mar 8.
9
Isoelectric focusing of Tamm-Horsfall glycoproteins: a simple tool for recognizing recurrent calcium oxalate renal stone formers.Tamm-Horsfall糖蛋白的等电聚焦:一种识别复发性草酸钙肾结石患者的简单工具。
Urol Res. 1996;24(2):79-82. doi: 10.1007/BF00431083.
10
Citrate determines calcium oxalate crystallization kinetics and crystal morphology-studies in the presence of Tamm-Horsfall protein of a healthy subject and a severely recurrent calcium stone former.柠檬酸盐决定草酸钙结晶动力学和晶体形态——在健康受试者和严重复发性钙结石患者的Tamm-Horsfall蛋白存在下的研究。
Nephrol Dial Transplant. 2000 Mar;15(3):366-74. doi: 10.1093/ndt/15.3.366.

引用本文的文献

1
Isoelectric focusing of Tamm-Horsfall glycoproteins: a simple tool for recognizing recurrent calcium oxalate renal stone formers.Tamm-Horsfall糖蛋白的等电聚焦:一种识别复发性草酸钙肾结石患者的简单工具。
Urol Res. 1996;24(2):79-82. doi: 10.1007/BF00431083.
2
A simple diagnostic method for the differentiation of Tamm-Horsfall glycoproteins from healthy probands and those from recurrent calcium oxalate renal stone formers.一种用于区分健康受试者与复发性草酸钙肾结石患者的Tamm-Horsfall糖蛋白的简单诊断方法。
Experientia. 1995 Nov 15;51(11):1068-72. doi: 10.1007/BF01946918.

本文引用的文献

1
Characterization and separation of an inhibitor of viral hemagglutination present in urine.尿液中存在的病毒血凝抑制物的特性鉴定与分离
Proc Soc Exp Biol Med. 1950 May;74(1):106-8.
2
The oxalate-tolerance-value: a whole urine method to discriminate between calcium oxalate-stoneformers and others.草酸盐耐受值:一种区分草酸钙结石形成者和其他人的全尿检测方法。
Urol Res. 1985;13(6):291-5. doi: 10.1007/BF00262659.
3
Crystallization conditions in urine of patients with idiopathic recurrent calcium nephrolithiasis and with hyperparathyroidism.
Urol Res. 1985;13(4):169-74. doi: 10.1007/BF00261818.
4
Saturation-inhibition index as a measure of the risk of calcium oxalate stone formation in the urinary tract.
N Engl J Med. 1976 Jan 29;294(5):249-52. doi: 10.1056/NEJM197601292940504.
5
Uromucoid excretion of normal individuals and stone formers.正常人和结石形成者的尿类黏蛋白排泄情况。
Br J Urol. 1975;47(7):733-7. doi: 10.1111/j.1464-410x.1975.tb04050.x.
6
Estimation of the state of saturation of brushite and calcium oxalate in urine: a comparison of three methods.尿液中透钙磷石和草酸钙饱和度状态的评估:三种方法的比较。
J Lab Clin Med. 1977 Apr;89(4):891-901.
7
A new urinary test for stone "activity".一种用于检测结石“活性”的新型尿液检测方法。
Br J Urol. 1978 Dec;50(7):442-8. doi: 10.1111/j.1464-410x.1978.tb06188.x.
8
A biochemical basis for grouping of patients with urolithiasis.尿石症患者分组的生化基础。
Eur Urol. 1978;4(4):241-9. doi: 10.1159/000473965.
9
The expectation of free and fixed particles in urinary stone disease.尿路结石病中游离和固定颗粒的预期情况。
Invest Urol. 1978 May;15(6):442-8.
10
Uromucoid excretion in normal subjects, calcium stone formers and in patients with chronic renal failure.正常受试者、钙结石形成者及慢性肾衰竭患者的尿类黏蛋白排泄情况。
Urol Res. 1979 Mar 23;7(1):5-12. doi: 10.1007/BF00262919.